help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on April 3, 2008, doi:10.1165/rcmb.2007-0406OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0406OCv1
39/3/364    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Shetty, P.
Right arrow Articles by Shetty, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shetty, P.
Right arrow Articles by Shetty, S.
American Journal of Respiratory Cell and Molecular Biology. Vol. 39, pp. 364-372, 2008
© 2008 American Thoracic Society
DOI: 10.1165/rcmb.2007-0406OC

Urokinase Expression by Tumor Suppressor Protein p53

A Novel Role in mRNA Turnover

Praveenkumar Shetty1,*, Thirunavukkarasu Velusamy1,*, Yashodhar P. Bhandary1,*, Rashmi S. Shetty1, Ming-Cheh Liu2 and Sreerama Shetty1

1 Texas Lung Injury Institute, Department of Specialty Care Services, The University of Texas Health Center at Tyler, Tyler, Texas; and 2 Department of Pharmacology, College of Pharmacy, The University of Toledo, Toledo, Ohio

Correspondence and requests for reprints should be addressed to Sreerama Shetty, Ph.D., Professor of Medicine, The Texas Lung Injury Institute, Department of Specialty Care Services, The University of Texas Health Center at Tyler, 11937 U.S. Highway 271, Lab C-6, Tyler, TX 75708. E-mail: sreerama.shetty{at}uthct.edu

Lung carcinoma (H1299) cells deficient in p53 (p53–/–) express large amounts of urokinase-type plasminogen activator (uPA) protein and uPA mRNA, and exhibit slower degradation of uPA mRNA than that of p53-expressing nonmalignant Beas2B human airway epithelial cells. Expression of p53 protein in H1299 cells, upon transfection with p53 cDNA, suppressed basal as well as uPA-induced expression of uPA protein in both conditioned media and cell lysates, and decreased the level of steady-state uPA mRNA primarily due to increased uPA mRNA turnover. Inhibition of p53 expression by RNA silencing (SiRNA) in Beas2B cells enhanced basal and uPA-mediated uPA protein and mRNA expression with stabilization of uPA mRNA. Purified p53 binds to the uPA mRNA 3' untranslated region (UTR) in a sequence-specific manner and endogenous uPA mRNA associates with p53 protein isolated from Beas2B cytosolic extracts. p53 binds to a 35-nucleotide uPA 3'UTR sequence and insertion of this sequence into β-globin mRNA accelerates degradation of otherwise stable β-globin mRNA. These observations confirm a new role for p53 as a uPA mRNA binding protein that down-regulates uPA mRNA stability and decreases cellular uPA expression.

Key Words: post-transcriptional regulation • urokinase-type plasminogen activator • p53 • mRNA stability • RNA binding protein


CLINICAL RELEVANCE

The current study describes the underlying mechanism involved in lung epithelial cell death during injury such as acute respiratory distress syndrome or acute lung injury.

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2008 American Thoracic Society.
  ATS Best of the Web